跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DEXIMUNE CAPSULES 25MG - HSA Drug Approval Details
Approvals
/
HSA
/
DEXIMUNE CAPSULES 25MG
Approved
THERAPEUTIC
DEXIMUNE CAPSULES 25MG
SWISS CAPS AG - SWITZERLANDDEXCEL LTD. (PRIMARY AND SECONDARY PACKAGER) (ISRAEL)
🇸🇬 Health Sciences Authority
Approval Date
Nov 9, 2011
Approval ID
52bc0cec03d85635
Company
SWISS CAPS AG - SWITZERLANDDEXCEL LTD. (PRIMARY AND SECONDARY PACKAGER) (ISRAEL)
Type
Therapeutic
Approval Details
Approval Id
52bc0cec03d85635
Drug Name
DEXIMUNE CAPSULES 25MG
Product Name
DEXIMUNE CAPSULES 25MG
Approval Number
SIN14047P
Approval Date
2011-11-09
Registrant
APEX PHARMA MARKETING PTE. LTD.
Licence Holder
APEX PHARMA MARKETING PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
CAPSULE, LIQUID FILLED
Route Of Administration
ORAL
Atc Code
L04AD01
Atc Item Name
ciclosporin
Pharma Manufacturer Name
APEX PHARMA MARKETING PTE. LTD.
Active Ingredients
CICLOSPORIN
25.00MG
CICLOSPORIN
25 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Nov 9, 2011
Approval ID
52bc0cec03d85635
Type
Therapeutic
Back to HSA Approvals